openPR Logo
Press release

Open Therapeutics and American Impact Capital Foundation Form Alliance

12-13-2022 02:03 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Open Therapeutics

open science Therapoid platform by Open Therapeutics

open science Therapoid platform by Open Therapeutics

American Impact Capital Foundation Provides Non-Fungible Token (NFT) and Cryptocurrency Holders a Route for Philanthropic and Charitable Giving.

Cincinnati, OH and Westport, CT - December 12th, 2022 - Open Therapeutics [ https://OpenTherapeutics.org ], an open science company, announces an alliance with American Impact Capital Foundation [ https://americanimpactcapital.com/ ]. Through this alliance, members of the Open Therapeutics' Therapoid [ https://Therapoid.net/ ] community who wish to donate their NFTs and cryptocurrency assets to charities now have a unique pathway to do so.

American Impact Capital (AIC) amplifies the impact of philanthropic capital that is aligned with the United Nations Sustainable Development Goals [ https://sdgs.un.org/goals/ ].

Through its innovative IRS-approved funding model, AIC invests philanthropic capital in private companies that are positively impacting social and environmental causes. Based upon the recommendations of its donors, AIC invests in, and makes grants to cause areas such as health and wellness, clean energy, and sustainable food.

Similarly, Open Therapeutics' mission is enabling the global research community to positively impact human, animal, plant, and global environmental health. At its core, the Therapoid open science platform provides unique discussion forums controlled by the community [ https://therapoid.net/en/forums/ ]

As members collaborate, they gain ScienceCoins cryptocurrency and NFT awards. Through this alliance, AIC provides members a unique pathway to donate their ScienceCoins and NFTs into charities and socially responsible companies.

According to Peter McCrea, President of American Impact Capital, "We are extremely proud to be part of this highly important venture. We have been huge fans of the Open Therapeutics model from the beginning, and we look forward to collaborating with Open Therapeutics through their Therapoid platform. On behalf of our donors, we source outstanding impact investment opportunities and provide an untapped philanthropic funding channel for innovative entrepreneurs and forward-thinking nonprofit organizations. We look forward to providing this service to ScienceCoins and NFT holders."

Jason E. Barkeloo, Founder of Open Therapeutics adds, "American Impact Capital is a visionary leader in philanthropic capital investing. As a result of this exciting alliance, we are enabling ScienceCoins and NFT holders a pathway to donate their crypto holdings through AIC into socially and environmentally conscious philanthropic causes."

For a limited time, when researchers freely register at Therapoid, they gain complimentary ScienceCoins.

Also, when Therapoid members navigate to AIC through Therapoid, they will gain additional ScienceCoins. The complimentary ScienceCoins awards are only available through the end of January 2023.

Further, those that register are also entered into a random give-away of one of five hundred serial numbered "Scientists of Interest" NFTs. This unique NFT has a physical half, which matches to a digital half. The drawing is anticipated to occur in early 2023. Awardees will be able to donate their NFTs to a charity through AIC.

###

About American Impact Capital Foundation
American Impact Capital Foundation (AIC) provides philanthropic advisory and philanthropic funding services. In addition to our philanthropic capabilities, we have medical, legal, scientific, and tax planning expertise. We collaborate closely with Donor Advised Funds (DAFs) and Private Foundations to facilitate the investment of philanthropic capital in entrepreneurial companies and support effective nonprofit organizations that are driven to make a positive social and environmental impact in the world. We believe in Regenerative Capitalism and market-driven impact. We strive for transformation rather than disruption and we bring an institutional, for-profit sensibility to philanthropy and social impact investing.

Media Contact:
Peter McCrea, President
American Impact Capital Foundation, Inc.
peter@americanimpactcapital.com
203-246-8610
www.americanimpactcapital.com
501(c)(3) EIN: 83-1832513

PO Box 307
Westport, CT 06881
USA

About Open Therapeutics
The Company freely provides the scientific community the Therapoid platform; an open science and open access collaboration ecosystem that puts scientists and students at the center of research for positively impacting human, animal, plant, and global environmental health. At the center of Therapoid are discussion Forums. The Forums provide a sanctuary-like environment for students, researchers, press, and even citizen scientists. Users also have access intellectual properties (IP), grant funding, free equipment, manuscripts, knowledge content center career opportunities. When members use Therapoid, they are awarded Polygon blockchain-based decentralized science (DeSci) controlled ScienceCoins cryptocurrency and non-fungible tokens (NFTs). Member use of Therapoid is governed under a comprehensively modified Creative Commons 4.0 ShareAlike (CC4.0 ShareAlike) license. Through creating the world's biggest think tank, members who openly engage can be seen by employers.

Media Contact:
Jason E. Barkeloo, Founder/Chair
Open Therapeutics
+1.513.252.2901
https://Therapoid.net
Info@OpenTherapeutics.org
Twitter: https://twitter.com/OpenTherapeutic
Telegram: https://t.me/Therapoid
PO Box 30085
Cincinnati, OH 45230
USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Open Therapeutics and American Impact Capital Foundation Form Alliance here

News-ID: 2845376 • Views:

More Releases from Open Therapeutics

Open Therapeutics is Awarded a Grant from the Blockchain-based Polygon Decentralized Autonomous Organization (PolygonDAO)
Open Therapeutics is Awarded a Grant from the Blockchain-based Polygon Decentral …
Through this award, Open Therapeutics will accelerate its Web3.0 Polygon blockchain implementation. Cincinnati, OH, and Polygon DAO - November 8, 2022 - Open Therapeutics (https://OpenTherapeutics.org), an open science company was awarded a grant from the leading blockchain developer organization, the Polygon Decentralized Autonomous Organization (Polygon DAO). The PolygonDAO is a global blockchain developer community that aims to decentralize, grow, and innovate the Polygon blockchain community. With over 68,000 members in its Official
Open Therapeutics and IPwe Form an Intellectual Property Partnership.
Open Therapeutics and IPwe Form an Intellectual Property Partnership.
Through a partnership to enhance the licensing of intellectual properties, the companies will work to jointly encourage the licensing of IP portfolios Cincinnati, OH, and Paris, France - September 14th, 2022 - Open Therapeutics, an open science company, and IPwe, a global platform leveraging the power of artificial intelligence, predictive analytics, and blockchain technology around smart intangible asset management, announce their collaboration to jointly advance the licensing of intellectual property. Open Therapeutics'
Timmaron Group of Minnesota invests in Open Therapeutics, LLC
Timmaron Group of Minnesota invests in Open Therapeutics, LLC
Open Therapeutics, LLC owns Therapoid. Therapoid is a scientific collaboration platform that crowdsources scientists, particularly the underserved in Africa, Asia, and Latin America, around freely provided Intellectual property. Therapoid not only provides IP, but grants, free lab equipment, manuscript development tools, and preprint server for achieving open access publications and pushing technology development forward. For more information about Open Therapeutics visit (https://OpenTherapeutics.org) or visit (https://Therapoid.net) to register.

All 4 Releases


More Releases for Therapoid

Open Therapeutics is Awarded a Grant from the Blockchain-based Polygon Decentral …
Through this award, Open Therapeutics will accelerate its Web3.0 Polygon blockchain implementation. Cincinnati, OH, and Polygon DAO - November 8, 2022 - Open Therapeutics (https://OpenTherapeutics.org), an open science company was awarded a grant from the leading blockchain developer organization, the Polygon Decentralized Autonomous Organization (Polygon DAO). The PolygonDAO is a global blockchain developer community that aims to decentralize, grow, and innovate the Polygon blockchain community. With over 68,000 members in its Official
Open Therapeutics and IPwe Form an Intellectual Property Partnership.
Through a partnership to enhance the licensing of intellectual properties, the companies will work to jointly encourage the licensing of IP portfolios Cincinnati, OH, and Paris, France - September 14th, 2022 - Open Therapeutics, an open science company, and IPwe, a global platform leveraging the power of artificial intelligence, predictive analytics, and blockchain technology around smart intangible asset management, announce their collaboration to jointly advance the licensing of intellectual property. Open Therapeutics'
Timmaron Group of Minnesota invests in Open Therapeutics, LLC
Open Therapeutics, LLC owns Therapoid. Therapoid is a scientific collaboration platform that crowdsources scientists, particularly the underserved in Africa, Asia, and Latin America, around freely provided Intellectual property. Therapoid not only provides IP, but grants, free lab equipment, manuscript development tools, and preprint server for achieving open access publications and pushing technology development forward. For more information about Open Therapeutics visit (https://OpenTherapeutics.org) or visit (https://Therapoid.net) to register.
Open Therapeutics Launches Strategic Partnership with The Knight Group
Open Therapeutics, a St. Paul, MN based company that curates and develops open medical, biopharma and synthetic biology-based biotechnologies, has entered into a strategic partnership with The Knight Group, a Cleveland based executive search firm specializing in scientific staffing. The Knight Group, led by CEO Ray Knight, will source talent via internal resources and Open Therapeutics’ Therapoid web platform under the auspices of a shared revenue model. “This venture,
Open Therapeutics Receives Oklahoma Medical Research Foundation’s Dormant Inte …
Open Therapeutics Receives Oklahoma Medical Research Foundation’s Dormant Intellectual Property. The intellectual property is available on the scientific collaboration platform, Therapoid™. Minneapolis, MN– August 7, 2018 – Open Therapeutics LLC, a scientific collaboration platform company, received dormant intellectual property (IP) from the Oklahoma Medical Research Foundation (OMRF). According to Jason E. Barkeloo, Founder and Chair of Open Therapeutics, “Open Therapeutics in-licenses and accepts dormant, orphan, and abandoned IP from institutions and organizations
Open Therapeutics Announced as a Winner of Freedom from Cancer Startup Challenge
Minneapolis, MN and Bethesda, MD – July 26, 2018 – Open Therapeutics LLC, a scientific collaboration platform company, is a winner of the Center for Advancing Innovation (CAI) Freedom from Cancer Startup Challenge (FCSC). The FCSC, generously supported by the Laura and John Arnold Foundation and MedImmune®, has an overarching goal to advance more than one hundred inventions to prevent, diagnose and/or treat cancer. The inventions were developed at fifty-five institutions,